The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

JAMA Oncology - Tập 3 Số 12 - Trang 1683 - 2017
Tomi Akinyemiju1, Semaw Ferede Abera2,3, Muktar Beshir Ahmed4, Noore Alam5,6, Mulubirhan Assefa Alemayohu7, Christine A. Allen8, Rajaa Al‐Raddadi9, Nelson Alvis‐Guzmán10, Yaw Ampem Amoako11, Al Artaman12, Tadesse Awoke Ayele13, Aleksandra Barać14, Isabela M. Benseñor15, Adugnaw Berhane16, Zulfiqar A Bhutta17,18, Jacqueline Castillo-Rivas19, Abdulaal Chitheer20, Jee-Young Jasmine Choi21, Benjamin Cowie22, Lalit Dandona23,8, Rakhi Dandona23,8, Subhojit Dey24, Daniel Dicker8, Huyen Phuc25, Donatus U. Ekwueme26, Maysaa El Sayed Zaki27, Florian Fischer28, Thomas Fürst29,30,31, Jamie Hancock8, Simon I Hay8, Peter J. Hotez32,33, Sun Ha Jee34, Amir Kasaeian35, Yousef Khader36, Young‐Ho Khang37, G Anil Kumar38, Michael Kutz8, Heidi J. Larson39, Alan D Lopez40,8, Raimundas Lunevičius41,42, Reza Malekzadeh43, Colm McAlinden44, Toni Meier45, Walter Mendoza46, Ali H. Mokdad8, Maziar Moradi‐Lakeh47,48, Gabriele Nagel49, Quyen Le Nguyen25, Grant Nguyen8, Felix Akpojene Ogbo50,51, George Patton52, David M. Pereira53, Farshad Pourmalek54, Mostafa Qorbani55, Amir Radfar56, Gholamreza Roshandel57, Joshua A. Salomon58, Juan Sanabria59,60, Benn Sartorius61, Maheswar Satpathy62,63, Monika Sawhney64, Sadaf G Sepanlou43, Katya Anne Shackelford8, Hirbo Shore Roba65, Jiandong Sun66, Desalegn Tadese Mengistu67, Roman Topór-Mądry68,69, Bach Xuan Tran70,71, Kingsley Nnanna Ukwaja72, Vasily Vlassov73, Dan J. Stein74,75, Theo Vos8, Tolassa Wakayo76, Elisabete Weiderpass77,78,79, Andrea Werdecker80, Naohiro Yonemoto81, Mustafa Z Younis82,83, Chuanhua Yu84, Zoubida Zaidi85,86, Liguo Zhu87, Christopher J L Murray8, Mohsen Naghavi8, Christina Fitzmaurice88,8
1School of Public Health, Birmingham, University of Alabama at Birmingham
2Mekelle University, School of Public Health, College of Health Sciences, Mekelle, Tigray, Ethiopia
3University of Hohenheim, Institute of Biological Chemistry and Nutrition, Stuttgart, Baden Württemberg, Germany
4Jimma University Institute of Health, Department of Epidemiology, Jimma, Oromiya, Ethiopia
5Department of Health, Queensland Government, Herston, QLD, Australia
6University of Queensland, School of Public Health, Herston, QLD, Australia
7Mekelle University Epidemiology, Mekelle, TNRS, Ethiopia
8University of Washington, Institute for Health Metrics and Evaluation, Seattle
9Ministry of Health Research Department, Jeddah, Saudi Arabia
10Universidad de Cartagena, Grupo de Investigación en Economía de la Salud, Cartagena, Bolivar, Colombia
11Komfo Anokye Teaching Hospital, Department of Medicine, Bantama, Ghana
12University of Manitoba, Community Health Sciences, Winnipeg, Manitoba, Canada
13University of Gondar, Epidemiology and Biostatistics, Gondar, Ethiopia
14Clinical Center of Serbia, Clinic for Infectious and Tropic Diseases, Belgrade, Serbia
15Hospital Universitário, University of São Paulo Division of Internal Medicine, São Paulo, São Paulo, Brazil
16Debre Berhan University, College of Health Sciences, Debre Berhan, Amhara, Ethiopia
17Aga Khan University, Centre of Excellence in Women & Child, Karachi, Sindh, Pakistan
18The Hospital for Sick Children, Centre for Global Child Health, Toronto, Ontario, Canada
19Caja Costarricense de Seguro Social, Dirección Actuarial y Economica, San Jose, San Jose, Costa Rica
20Iraq MOH FETP, MOH, Baghdad, Iraq
21Seoul National University, College of Medicine Medical Library, Seoul, South Korea
22Doherty Institute, WHO Collaborating Centre for Viral Hepatitis, Melbourne, Victoria, Australia
23Public Health Foundation of India, Research, Gurgaon, NCR, India
24Indian Institute of Public Health-Delhi, Environmental and Occupational Health, Gurgaon, Haryana, India
25Duy Tan University, Institute for Global Health Innovations, Da Nang, Vietnam
26Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
27Clinical Pathology Department, Mansoura Faculty of Medicine, Mansoura, Egypt
28Bielefeld University, School of Public Health, Bielefeld, Germany
29Imperial College London, School of Public Health, London, England
30Swiss Tropical and Public Health Institute, Epidemiology and Public Health, Basel, Switzerland
31University of Basel, Switzerland
32Baylor College of Medicine, National School of Tropical Medicine, Houston, Texas
33Sabin Vaccine Institute & Texas Children's Hospital Center for Vaccine Development, Houston
34Graduate School of Public Health, Yonsei University, Epidemiology and Health Promotion, Seoul, South Korea
35Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran, Tehran, Iran
36Jordan University of Science and Technology, Public Health, Irbid, Irbid, Jordan
37Seoul National University College of Medicine, Institute of Health Policy and Management, Seoul, Seoul Metropolitan City, South Korea
38Public Health Foundation of India Research, Gurgaon (NCR), Haryana, India
39Department Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England
40University of Melbourne, Melbourne School of Population and Global Health, Melbourne, VIC, Australia
41Aintree University Hospital NHS Foundation Trust, General Surgery Department, Liverpool, England
42School of Medicine, University of Liverpool, Liverpool, England
43Tehran University of Medical Sciences, Digestive Diseases Research Institute, Tehran, Tehran, Iran
44University Hospitals Bristol, Department of Medicine, Bristol, England
45Martin Luther University Halle-Wittenberg, Institute for Agricultural and Nutritional Sciences, Halle (Saale), Germany
46UNFPA Peru Country Office, Lima, Peru
47Iran University of Medical Sciences, Gastrointestinal and Liver Disease Research Center, Tehran, Tehran, Iran
48Iran University of Medical Sciences, Preventive Medicine and Public Health Research Center, Tehran, Tehran, Iran
49Ulm University, Institute of Epidemiology and Medical Biometry, Ulm, Germany
50Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia
51Western Sydney University, Centre for Health Research, School of Medicine, Penrith, NSW, Australia
52University of Melbourne, Paediatrics, Melbourne, Victoria, Australia
53REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
54Department of Urology, University of British Columbia, Vancouver, British Columbia, Canada
55Alborz University of Medical Sciences, Noncommunicable Diseases Research Center, Karaj, Alborz, Iran
56A. T. Still University, College of Graduate Health Studies, Mesa, Arizona
57Golestan University of Medical Sciences, Golestan Research Center of Gastroenterology and Hepatology, Gorgan, Iran
58Harvard T.H. Chan School of Public Health, Department of Global Health and Population, Boston, Massachusetts
59Case Western Reserve University, Nutrition and Preventive Medicine, Ohio
60Marshall University School of Medicine, Surgery, Huntington, West Virginia
61University of KwaZulu-Natal, Public Health Medicine, Durban, KwaZulu-Natal, South Africa
62AIIMS New Delhi, JPN Apex Trauma Centre, New Delhi, Delhi, India
63Utkal University, Centre for Advanced Study in Psychology, Bhubaneswar, Odisha, India
64Marshall University Public Health, Huntington, West Virginia
65Haramaya University School of Public Health, Harari, Harari, Ethiopia
66Queensland University of Technology, School of Public Health and Social Work, Brisbane, Queensland, Australia
67Mekelle University, Institute of Biomedical Sciences, Mekelle, Tigrai, Ethiopia
68Faculty of Health Sciences Jagiellonian University Medical College, Institute of Public Health, Kraków, Poland
69Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland
70Hanoi Medical University, Institute for Preventive Medicine and Public Health, Hanoi, Vietnam
71Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
72Federal Teaching Hospital, Department of Medicine, Abakaliki, Ebonyi State, Nigeria
73Department of Health Care Administration and Economy, National Research University Higher School of Economics, Moscow, Russia
74Norwegian Institute of Public Health, Centre for Disease Burden, Bergen, Norway
75University of Bergen, Department of Global Public Health and Primary Care, Bergen, Norway
76Jimma University, Population and Family Health, Oromia, Ethiopia
77Cancer Registry of Norway, Institute of Population‐based Cancer Research, Oslo, Norway
78Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
79University of Tromsø, The Arctic University of Norway, Department of Community Medicine, Faculty of Health Sciences, Tromsø, Norway
80Federal Institute for Population Research, Competence Center Mortality-Follow-Up of the National Cohort, Wiesbaden, Hesse, Germany
81Kyoto University, School of Public Health Biostatistics, Sakyo, Kyoto, Japan
82Harvard Asia Aging Center, Harvard Medical School, Boston, Massachuetts
83Jackson State University, Health Policy & Management, Jackson, Mississippi
84Department of Epidemiology and Biostatistics, Wuhan University, Wuhan, Hubei Province, China
85Department of Epidemiology, University Hospital of Setif, Setif, Algeria
86University Ferhat Abbas, Faculty of Medicine, Setif, Algeria
87Jiangsu Provincial Center for Disease Control and Prevention, Major Project Execution Office, Nanjing, Jiangsu, China
88Division of Hematology, Department of Medicine, University of Washington, Seattle

Tóm tắt

Từ khóa


Tài liệu tham khảo

GBD 2015 Mortality and Causes of Death Collaborators, 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015., Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1

Petrick, 2016, International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007., Int J Cancer, 139, 1534, 10.1002/ijc.30211

Chuang, 2009, Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection., Cancer Lett, 286, 9, 10.1016/j.canlet.2008.10.040

Lauby-Secretan, 2016, Body fatness and cancer—viewpoint of the IARC Working Group., N Engl J Med, 375, 794, 10.1056/NEJMsr1606602

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012., Int J Cancer, 136, E359, 10.1002/ijc.29210

Ryerson, 2016, Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer., Cancer, 122, 1312, 10.1002/cncr.v122.9

Fan, 2013, Attributable causes of liver cancer mortality and incidence in china., Asian Pac J Cancer Prev, 14, 7251, 10.7314/APJCP.2013.14.12.7251

Asim, 2013, Etiological and molecular profile of hepatocellular cancer from India., Int J Cancer, 133, 437, 10.1002/ijc.v133.2

Plummer, 2016, Global burden of cancers attributable to infections in 2012: a synthetic analysis., Lancet Glob Health, 4, e609, 10.1016/S2214-109X(16)30143-7

Makarova-Rusher, 2016, Population attributable fractions of risk factors for hepatocellular carcinoma in the United States., Cancer, 122, 1757, 10.1002/cncr.29971

de Martel, 2015, World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma., Hepatology, 62, 1190, 10.1002/hep.27969

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, 2016, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015., Lancet, 388, 1545, 10.1016/S0140-6736(16)31678-6

Global Burden of Disease Cancer Collaboration, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study., JAMA Oncol

Foreman, 2012, Modeling causes of death: an integrated approach using CODEm., Popul Health Metr, 10, 1, 10.1186/1478-7954-10-1

Salomon, 2012, Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010., Lancet, 380, 2129, 10.1016/S0140-6736(12)61680-8

Bosetti, 2014, Hepatocellular carcinoma epidemiology., Best Pract Res Clin Gastroenterol, 28, 753, 10.1016/j.bpg.2014.08.007

Center, 2011, International trends in liver cancer incidence rates., Cancer Epidemiol Biomarkers Prev, 20, 2362, 10.1158/1055-9965.EPI-11-0643

McGlynn, 2011, The global epidemiology of hepatocellular carcinoma: present and future., Clin Liver Dis, 15, 223, 10.1016/j.cld.2011.03.006

Nayagam, 2016, Requirements for global elimination of hepatitis B: a modelling study., Lancet Infect Dis, 16, 1399, 10.1016/S1473-3099(16)30204-3

Ward, 2015, Simple, effective, but out of reach? public health implications of HCV drugs., N Engl J Med, 373, 2678, 10.1056/NEJMe1513245

Edwards, 2015, Access to hepatitis C medicines., Bull World Health Organ, 93, 799, 10.2471/BLT.15.157784

Guirguis, 2015, Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States., Alcohol Clin Exp Res, 39, 2085, 10.1111/acer.12887

Liu, 2010, Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment., Environ Health Perspect, 118, 818, 10.1289/ehp.0901388

Fürst, 2012, Global burden of human food-borne trematodiasis: a systematic review and meta-analysis., Lancet Infect Dis, 12, 210, 10.1016/S1473-3099(11)70294-8

Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes., Hepatology, 64, 73, 10.1002/hep.v64.1

Chen, 2014, Incidence trend of liver cancer: an analysis of 40 years data from Qidong population-based cancer registry., Zhongguo Zhong Liu, 23, 621

Zheng, 2015, [Mortality and survival analysis of liver cancer in China]., Zhonghua Zhong Liu Za Zhi, 37, 697

Sun, 2013, Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China., Carcinogenesis, 34, 1800, 10.1093/carcin/bgt007

Hao, 2003, Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population., Eur J Cancer Prev, 12, 273, 10.1097/00008469-200308000-00006

Chimed, 2017, Cancer incidence and cancer control in Mongolia: results from the National Cancer Registry 2008-2012., Int J Cancer, 140, 302, 10.1002/ijc.v140.2

Mitchell, 2011, The increasing burden of imported chronic hepatitis B--United States, 1974-2008., PLoS One, 6, e27717, 10.1371/journal.pone.0027717

Cohen, 2011, Is chronic hepatitis B being undertreated in the United States?, J Viral Hepat, 18, 377, 10.1111/jvh.2011.18.issue-6

Llovet, 2008, Sorafenib in advanced hepatocellular carcinoma., N Engl J Med, 359, 378, 10.1056/NEJMoa0708857

Connell, 2016, Advanced hepatocellular cancer: the current state of future research., Curr Treat Options Oncol, 17, 43, 10.1007/s11864-016-0415-3

Polednak, 2013, Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999-2010., J Registry Manag, 40, 168

Percy, 1990, The accuracy of liver cancer as the underlying cause of death on death certificates., Public Health Rep, 105, 361

Ahern, 2011, Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease., Popul Health Metr, 9, 8, 10.1186/1478-7954-9-8

Chang, 2016, The hepatitis viral status in patients with hepatocellular carcinoma: a study of 3843 patients from Taiwan Liver Cancer Network., Medicine (Baltimore), 95, e3284, 10.1097/MD.0000000000003284

Flaxman, 2015, An Integrative Metaregression Framework for Descriptive Epidemiology

Das Gupta, 1993, Standardization and Decomposition of Rates: a User’s Manual

International Agency for Research on Cancer. Known causes and prevention of human cancer by organ site. August 2016. http://monographs.iarc.fr/ENG/Publications/OrganSitePoster.pdf. Accessed August 7, 2017.

World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. June 2016. http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed September 9, 2016.

World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. 2013. http://www.who.int/nmh/publications/ncd-action-plan/en/.

World Health Organization. Global strategy to reduce harmful use of alcohol. WHO. http://www.who.int/substance_abuse/activities/gsrhua/en/. Accessed December 10, 2016.

National Comprehensive Cancer Network. NCCN Guidelines Hepatocellular Carcinoma. Version 2.2016. 2016. https://www.nccn.org/. Accessed April 15, 2017.

Thông tin
Thông tin xuất bản

JAMA Oncology

Tập 3 Số 12

1683

Thông tin tác giả